Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions
| Formato: | Electrónico Libro electrónico |
|---|---|
| Lenguaje: | Inglés |
| Publicado: |
Marketline
2007
|
| Materias: | |
| Acceso en línea: | Available in Business Source Complete. |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
Ejemplares similares
-
Lyrica Case Study: Building a Successful Drug Launch Strategy
Publicado: (2008) -
Topamax, Femara, & Torcetrapib Case Study: Utilizing Usage Extension to Broaden a Drug's Patient Base
Publicado: (2007) -
Osteoporosis Drug Reformulation Case Study: Refreshing a Brand Through Reformulation
Publicado: (2007) -
GlaxoSmithKline Case Study: Switching Drugs to OTC Status Effectively
Publicado: (2008) -
Avandia Case Study: How Negative Publicity Can Damage a Drug's Market Position
Publicado: (2008)